ribavirin has been researched along with Stroke in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abou-Samra, AB; Butt, AA; Freiberg, MS; Shaikh, OS; Shuaib, A; Yan, P | 1 |
Ho, HJ; Hsiao, NW; Hsu, YC; Huang, YT; Kao, YH; Lin, JT; Liu, YY; Wu, CY; Wu, MS | 1 |
Ho, HJ; Hsu, YC; Huang, YT; Lin, JT; Wang, HH; Wu, CY; Wu, MS | 1 |
1 trial(s) available for ribavirin and Stroke
Article | Year |
---|---|
Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients.
Topics: Acute Coronary Syndrome; Adult; Aged; Antiviral Agents; Cohort Studies; Comorbidity; Diabetes Mellitus; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C; Humans; Incidence; Interferon-alpha; Kidney Failure, Chronic; Male; Middle Aged; Multivariate Analysis; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors; Stroke; Taiwan; Treatment Outcome | 2014 |
2 other study(ies) available for ribavirin and Stroke
Article | Year |
---|---|
Direct-Acting Antiviral Therapy for HCV Infection Is Associated With a Reduced Risk of Cardiovascular Disease Events.
Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Antiviral Agents; Cardiovascular Diseases; Coronary Artery Bypass; Drug Therapy, Combination; Female; Heart Failure; Hepatitis C, Chronic; Humans; Incidence; Interferon Type I; Male; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Protective Factors; Ribavirin; Stroke; Sustained Virologic Response | 2019 |
Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection.
Topics: Acute Coronary Syndrome; Adult; Antiviral Agents; Autoimmune Diseases; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Kidney Failure, Chronic; Male; Middle Aged; Polyethylene Glycols; Proportional Hazards Models; Recombinant Proteins; Ribavirin; Stroke; Treatment Outcome | 2015 |